Project Grant K01HL174819
Award Date
8/15/24
Completion Date
7/31/29
Dollars Obligated
$162K
Federal Agency
National Heart Lung and Blood Institute
Federal Grant Program
93.837
Assistance Type
Project Grant
Place of Performance
Storrs, CT 06269, USA
Similar Awards
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $394,200 Project Grant under the Cardiovascular Diseases Research (CFDA 93.837) program to Weill Medical College of Cornell University. The grant supports the development and pilot testing of the COPDHEART intervention, a multicomponent behavioral program tailored to improve cardiovascular health among Black adults with chronic obstructive pulmonary disease (COPD). The project aims to identify barriers, refine the intervention...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), funded under the Cardiovascular Diseases Research program (CFDA 93.837), aims to pilot test the effectiveness of a culturally tailored virtual reality (VR)-based stress management program in addressing intersectional stress and improving cardiovascular health outcomes among hypertensive Black women. The University of Miami will receive $165,807 over a 5-year period starting August 1, 2024 to conduct focus...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,314,024 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to Weill Medical College of Cornell University to implement the "Coaching and Navigation by CHWs through Telehealth for High-Risk Hypertension" (CONNECT-HTN) intervention. The project aims to reduce death and hospitalization due to heart disease or stroke by connecting patients with severe hypertension to primary care resources and providing...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $815,229 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The University of Texas Southwestern Medical Center. The grant supports a 4-year research project to use proteomic and genomic analyses to identify biological mechanisms responsible for risk and resilience to heart failure and atrial fibrillation in Black Americans. The project will leverage data from the Jackson Heart Study to discover...
The National Heart, Lung, and Blood Institute (NHLBI), part of the National Institutes of Health, awarded a $639,165 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to The Washington University to develop an equitable and accessible wearable device for continuous calculation of blood loss for postpartum hemorrhage (PPH). The goal is to create a non-invasive sensor that can accurately monitor cardiovascular parameters and estimate blood loss, even with medical...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to optimize an evidence-based physical activity intervention for Latina women who do not meet physical activity guidelines. The $722,190 award to Brown University will integrate components from mindfulness-based stress reduction to improve adherence to physical activity among inactive Latina participants. The study will also rigorously evaluate stress as a...
This federal Project Grant award, funded by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), will support the development of a telemedicine intervention to improve hypertension management for Black patients. The $156,576 award, with a period of performance from September 1, 2024 to August 31, 2029, will be used by the prime awardee, Wake Forest University Health Sciences, to tailor a telemedicine-based hypertension management...
The National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research (CFDA 93.837) program, awarded a $310,948 Project Grant to Minnesota Healthsolutions Corporation, a for-profit woman-owned small business, on September 15, 2023. The grant funds the development of an adaptable platform to support patients with behavior change interventions aimed at improving adherence to treatment and prevention for multiple chronic diseases. The platform will utilize remote...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,052,276 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Lasarrus Clinic And Research Center Inc. The funding supports a 2-phase SBIR Fast-Track project to develop and validate a wearable multimodal sensor system for remote monitoring of chronic obstructive pulmonary disease (COPD) patients. The project aims to extend the awardee's patented "WearMe" platform to capture bilateral...
The National Heart, Lung, and Blood Institute (NHLBI) awarded a $1,847,271 Project Grant under CFDA 93.837 Cardiovascular Diseases Research to The Pennsylvania State University to develop a soft, stretchable, tissue-like bioadhesive electronic device for the long-term treatment of resistant hypertension. The project aims to create a minimally invasive device that can safely and effectively activate the carotid sinus baroreflex to reduce blood pressure in patients who are resistant to medication....